![John Lunger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Lunger
Keine laufenden Positionen mehr
Vermögen: 7 016 $ am 30.06.2026
Profil
John Lunger formerly worked at Genocea Biosciences, Inc., as Independent Director, Merrimack Pharmaceuticals, Inc., as Head-Supply Chain & Commercial Product Supply, and Adaptimmune Therapeutics Plc, as Chief Patient Supply Officer from 2019 to 2025.
Mr. Lunger received his undergraduate degree from United States Naval Academy and Masters Business Admin degree from The University of Chicago Booth School of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 11.04.2025 | 1.025.340 ( 0,06 % ) | 6 152 $ | 30.06.2026 | |
Lipella Pharmaceuticals, Inc.
 Lipella Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes lipid-based therapies for common bladder syndromes 0,16 % | 17.01.2025 | 7.510 ( 0,16 % ) | 864 $ | 30.06.2026 |
Ehemalige bekannte Positionen von John Lunger
| Unternehmen | Position | Ende |
|---|---|---|
| ADAPTIMMUNE THERAPEUTICS PLC | Corporate Officer/Principal | 29.08.2025 |
| MERRIMACK PHARMACEUTICALS | Corporate Officer/Principal | - |
| GENOCEA BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | - |
Ausbildung von John Lunger
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
26
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Genocea Biosciences, Inc.
 Genocea Biosciences, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company that discovers and develops novel cancer immunotherapies | Health Technology |
Merrimack Pharmaceuticals, Inc.
 Merrimack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes drugs for the treatment of immunological & autoimmune diseases and cancer | Health Technology |
United States Naval Academy
 United States Naval Academy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Chicago Booth School of Business
 The University of Chicago Booth School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adaptimmune Therapeutics Plc
 Adaptimmune Therapeutics Plc BiotechnologyHealth Technology Manufactures vaccines and cancer immunotherapy products | Health Technology |
